Jpmorgan Chase & CO Eyenovia, Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Eyenovia, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 723 shares of EYEN stock, worth $361. This represents 0.0% of its overall portfolio holdings.
Number of Shares
723
Previous 12,864
94.38%
Holding current value
$361
Previous $12,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding EYEN
# of Institutions
62Shares Held
11.8MCall Options Held
32.8KPut Options Held
7K-
Armistice Capital, LLC New York, NY6.06MShares$3.03 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$940,6450.0% of portfolio
-
Lasry Marc New York, NY548KShares$273,9030.33% of portfolio
-
Geode Capital Management, LLC Boston, MA409KShares$204,2610.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny393KShares$196,5860.0% of portfolio
About EYENOVIA, INC.
- Ticker EYEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,212,900
- Market Cap $17.1M
- Description
- Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...